Maze Therapeutics, Inc.
MAZE
$25.56
-$0.87-3.29%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -24.21M | -34.57M | -30.09M | -33.68M | -32.79M |
| Total Depreciation and Amortization | 444.00K | 499.00K | 571.00K | 649.00K | 684.00K |
| Total Amortization of Deferred Charges | 371.00K | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.96M | 6.65M | 4.37M | 4.02M | 4.01M |
| Change in Net Operating Assets | -23.68M | -311.00K | 501.00K | -1.04M | -1.43M |
| Cash from Operations | -39.11M | -27.73M | -24.64M | -30.05M | -29.52M |
| Capital Expenditure | -93.00K | -34.00K | -68.00K | -393.00K | -299.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 6.37M | -103.35M | -66.82M | -- | -- |
| Cash from Investing | 6.28M | -103.39M | -66.88M | -393.00K | -299.00K |
| Total Debt Issued | 39.40M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.08M | 3.59M | 143.76M | 612.00K | 127.88M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.12M | 0.00 | 0.00 | 0.00 | -500.00K |
| Cash from Financing | 42.36M | 3.59M | 143.76M | 612.00K | 127.38M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.52M | -127.53M | 52.23M | -29.83M | 97.56M |